Skip to main content Skip to main navigation menu Skip to site footer
ASIDE Endocrinology logo
  • Home
  • ASIDE Journals
    • ASIDE Internal Medicine
    • ASIDE Gastroenterology
    • ASIDE Case Reports
    • ASIDE Health Sciences
    • ASIDE Oncology
    • ASIDE Cardiovascular
    • ASIDE Endocrinology
    • ASIDE Neurosciences
    • ASIDE Infectious Diseases
  • Submissions
  • Call for Submissions
  • Archives
  • About
    • About the Journal
    • Editorial Team
    • Indexing
    • Privacy Statement
  • Contact
Search
  • Register
  • Login
  1. Home /
  2. Login

Login

Required fields are marked with an asterisk: *

Login
Register

Publish with us

  • Make a submission
  • Double-anonymous peer review
  • No fees at any stage
  • Crossref DOI on every article
  • Authors retain copyright

Author guidelines

Peer review

Model
Double-anonymous — authors and reviewers do not see each other’s identity
Screening
Editorial assessment for scope, then similarity screening
Handling
A named section editor oversees every submission

Full peer review policy

Journal at a glance

Indexed in
Crossref (DOIs)
Licence
CC BY 4.0, no fees
Peer review
Double-anonymous
DOAJ
Not yet listed

Preservation

  • Internet Archive
  • OAI-PMH harvesting enabled

Content stays available if this journal ceases publication.

Journal information

ISSN (Print)
3070-9091
ISSN (Online)
3070-9105
Publisher
PubPorta Publishing LLC
Academic oversight
American Society for Inclusion, Diversity, and Equity in Healthcare (ASIDE)
Contact
contact@asidejournals.com
Address
Delaware, USA

ASIDE Journals

  • ASIDE Cardiovascular
  • ASIDE Case Reports
  • ASIDE Gastroenterology
  • ASIDE Health Sciences
  • ASIDE Infectious Diseases
  • ASIDE Internal Medicine
  • ASIDE Neurosciences
  • ASIDE Oncology

Browse

  • Categories
    • Diabetes Mellitus
    • Obesity
    • Lipid
    • Thyroid
    • Bone
    • Pituitary
    • Adrenal Disorders
    • Reproductive

Open access and fees

  • No submission fee
  • No article processing charge
  • No charge for colour figures or extra pages
  • No subscription or paywall for readers

Every article is published open access under CC BY 4.0. Authors keep copyright; anyone may read, download and reuse the work with attribution.

Share

  • X
  • Facebook
  • LinkedIn
  • WhatsApp
  • Email

Join our social media

Join ASIDE Journals on social media — each logo opens our account in a new tab.

  • Bluesky
  • Mastodon
  • X
  • LinkedIn
  • Facebook
  • Telegram

Most read

  1. Efficacy and Safety of Lower- versus Higher-Dose Baxdrostat in Adults with Resistant or Uncontrolled Hypertension, Including a CKD-Enriched Population: An Indirect Subgroup Comparison from Placebo-Controlled Trials — A Systematic Review and Meta-Analysis with GRADE Assessment519 views
  2. Trends in Mortality Co‑Reporting Heart Failure and Metabolic Syndrome–Related Conditions Among U.S. Adults Aged ≥25 Years, 1999–2023: A CDC WONDER Analysis305 views

Abstract and full-text views, all time. Updated August 2026.

  • ASIDE Endocrinology
  • ISSN (Print) 3070-9091
  • ISSN (Online) 3070-9105
  • Published and owned by PubPorta Publishing LLC
  • 16192 Coastal Highway, Lewes, Delaware 19958, USA
  • Academic oversight and scholarly guidance are provided by the American Society for Inclusion, Diversity, and Equity in Healthcare (ASIDE)
  • Open Access · CC BY 4.0 — free to read, and free to reuse with credit to the original authors and source. Licence details
  • CC BY 4.0
  • Join us
  • Bluesky
  • Mastodon
  • X
  • LinkedIn
  • Facebook
  • Telegram
  • ASIDE Journals
  • ASIDE Internal Medicine
  • ASIDE Gastroenterology
  • ASIDE Case Reports
  • ASIDE Health Sciences
  • ASIDE Oncology
  • ASIDE Cardiovascular
  • ASIDE Endocrinology
  • ASIDE Neurosciences
  • ASIDE Infectious Diseases
  • For authors and readers
  • Submission guidelines
  • Call for submissions
  • Archives
  • Announcements
  • Indexing
  • Editorial masthead
  • About the journal
  • Contact
  • Privacy statement
  • Cookie settings
More information about the publishing system, Platform and Workflow by OJS/PKP.